Search results
ProQR (PRQR) Rises on Expanding RNA-Editing Deal With Eli Lilly
Zacks via Yahoo Finance· 1 year agoProQR (PRQR) expands its existing licensing and collaboration agreement with Eli Lilly for the...
ProQR Therapeutics N.V.'s (NASDAQ:PRQR) top owners are retail investors with 50% stake, while 31% is...
Simply Wall St. via Yahoo Finance· 10 months agoKey Insights The considerable ownership by retail investors in ProQR Therapeutics indicates that...
While institutions invested in ProQR Therapeutics N.V. (NASDAQ:PRQR) benefited from last week's 12%...
Simply Wall St. via Yahoo Finance· 5 months agoKey Insights Significant control over ProQR Therapeutics by individual investors implies that the...
ProQR (PRQR) Reports Q2 Loss, Lags Revenue Estimates
Zacks via Yahoo Finance· 2 years agoProQR (PRQR) delivered earnings and revenue surprises of 15.38% and 9.38%, respectively, for the quarter ended June 2022. Do the numbers hold clues to...
ProQR Therapeutics' (NASDAQ:PRQR) investors will be pleased with their impressive 109% return over...
Simply Wall St. via Yahoo Finance· 11 months agoProQR Therapeutics N.V. (NASDAQ:PRQR) shareholders might understandably be very concerned that the...
ProQR Therapeutics N.V. (NASDAQ:PRQR) Could Be Less Than A Year Away From Profitability
Simply Wall St. via Yahoo Finance· 1 year agoWe feel now is a pretty good time to analyse ProQR Therapeutics N.V.'s (NASDAQ:PRQR) business as it...
Individual investors account for 45% of ProQR Therapeutics N.V.'s (NASDAQ:PRQR) ownership, while...
Simply Wall St. via Yahoo Finance· 1 year agoTo get a sense of who is truly in control of ProQR Therapeutics N.V. (NASDAQ:PRQR), it is important...
ProQR Therapeutics (NASDAQ:PRQR) shareholders have endured a 83% loss from investing in the stock...
Simply Wall St. via Yahoo Finance· 1 year agoProQR Therapeutics N.V. (NASDAQ:PRQR) shareholders will doubtless be very grateful to see the share...
Investors in ProQR Therapeutics (NASDAQ:PRQR) have unfortunately lost 90% over the last three years
Simply Wall St. via Yahoo Finance· 2 years agoAs an investor, mistakes are inevitable. But really big losses can really drag down an overall...
ProQR Therapeutics Third Quarter 2022 Earnings: Revenues Beat Expectations, EPS Lags
Simply Wall St. via Yahoo Finance· 2 years agoProQR Therapeutics (NASDAQ:PRQR) Third Quarter 2022 ResultsKey Financial Results Net loss: €24.4m...